Cargando…
256. Serratia Marcescens Bacteremia and Endocarditis: A Treatment Assessment from an Academic Medical Center
BACKGROUND: Serratia Marcescens (SM) is often an opportunist that has been associated as a cause of healthcare-associated infection and in some people who inject drugs (PWID). Decisions about the treatment of SM infections are difficult given the small clinical studies available and concerns for mul...
Autores principales: | Slain, Douglas, Howard, Catessa, Cooper, Clinton G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778122/ http://dx.doi.org/10.1093/ofid/ofaa439.300 |
Ejemplares similares
-
Serratia marcescens Endocarditis
por: Elkattawy, Sherif, et al.
Publicado: (2021) -
187. Risk Factors and Outcomes of Patients with Serratia Bacteremia at an Academic Medical Center
por: Doktor, Katherine L, et al.
Publicado: (2023) -
1980. A Case Series of Serratia Marcescens Endocarditis in Persons Who Inject Drugs
por: Cook, Julia Christine, et al.
Publicado: (2022) -
96. Impact of Hospital-Based Pharmacist Discharge Prescription Review on the Appropriateness of Antibiotic Therapy
por: Spigelmyer, Amy, et al.
Publicado: (2021) -
Risk Factors for Mortality in Patients with Serratia marcescens Bacteremia
por: Kim, Sun Bean, et al.
Publicado: (2015)